Metraipolis › archive › dc_d035fb235293

Efficacy hierarchy and absolute survival benefit of first-line immunotherapy in advanced gastric cancer: a meta-analysis and pooled survival analysis — Europe PMC PMID:42676632

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42676632
DOI: 10.3389/fimmu.2026.1866848
License (as archived): solo-consultazione
Archived: 2026-10-08T13:35:59.913Z
SHA-256 of the archived text: 23bbcf6e37fd7603eaac128c150a8fd084f82ddd5138b55e6b92b7977cfde6c1
Stable URL of this page: https://metraipolis.com/documento/dc_d035fb235293

How to cite

Efficacy hierarchy and absolute survival benefit of first-line immunotherapy in advanced gastric cancer: a meta-analysis and pooled survival analysis — Europe PMC PMID:42676632 — Europe PMC (en), https://europepmc.org/article/MED/42676632 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d035fb235293 (Metraipolis archive dc_d035fb235293, sha256 23bbcf6e37fd7603eaac128c150a8fd084f82ddd5138b55e6b92b7977cfde6c1)

BibTeX

@misc{dcd035fb235293,
  title = {Efficacy hierarchy and absolute survival benefit of first-line immunotherapy in advanced gastric cancer: a meta-analysis and pooled survival analysis — Europe PMC PMID:42676632},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42676632},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d035fb235293; sha256 23bbcf6e37fd7603eaac128c150a8fd084f82ddd5138b55e6b92b7977cfde6c1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42676632. Agents can read the archived copy with the MCP tool read_document.